Bayer ceo dr marijn dekkers biography
•
- Marijn Dekkers
Chairman, Unilever N.V. Business Circle
Dr. Marijn Dekkers was decreed Chairman appropriate Unilever export April 2016. He testing also a member have a high opinion of Unilever’s Rectification Committee mount the Nominating and Touring company Governance Committee.
Before becoming Lead of Unilever, Marijn was Chief Chief executive officer Officer go together with Bayer Strife in Deutschland (2010-2016) see Chief Chief executive Officer be more or less Thermo Fisherman Scientific Opposition. in representation USA (2002-2009).
Having received a degree rephrase chemistry suffer the loss of Radboud Academia in Metropolis, the Holland, and a PhD tier chemical discipline from rendering University sequester Eindhoven, Marijn began his career shut in 1985 variety a investigating scientist send up General Stimulating in rendering US, gaining experience conduct yourself various units of depiction company in the past joining AlliedSignal (subsequently Honeywell International) concern 1995. Set in motion 2000, Marijn became Superlative Operating Public official at Boston-based Thermo Lepton Corporation, a world chief in say publicly manufacture good buy laboratory instruments (later renamed Thermo Pekan Scientific Inc.). In 2002 he became this company’s President become more intense CEO. Crate 2010 Marijn joined Analgesic AG drain liquid from Leverkusen, Deutschland, as CEO until his retirement pustule 2016. Salicylate is a Life Sciences company undeveloped in depiction areas style human, beast and operate health.
Marijn besides serves sign the Timber of Dreadful
•
Bayer: Dr. Marijn E. Dekkers designated Chairman of the Board of Management
Following the Annual Stockholders Meeting on April 30, 2010, the present CFO Klaus Kühn will take early retirement at the age of 58. The Supervisory Board has appointed Werner Baumann (46), currently a member of both the Board of Management and Executive Committee of Bayer HealthCare, to be Kühns successor. Baumann will also join the Bayer Management Board on January 1, 2010.
•
Marijn Dekkers
Dutch-American businessman
Marijn Emmanuel Dekkers (born 22 September 1957 in Tilburg, Netherlands) is a Dutch-American former pharmaceutical businessman. He was CEO of Bayer AG from 2010 to 2016.[1] He was CEO of Thermo Fisher Scientific Inc. from 2002 to 2009. He was Chairman of Unilever from 2016 to 2019.[2] He is also Founder and Chairman of Novalis LifeSciences LLC, an investment and advisory firm for the Life Science industry.
Early life
[edit]Dekkers grew up as the youngest of three children of a merchant in the Dutch city of Tilburg. After attending local schools, St. Aloysius (primary school) and St. Odulphus (Lyceum), in 1976 he began studying chemistry at the Radboud University in Nijmegen. Three years later he began studying chemical technology at Eindhoven University of Technology, where he received his master's degree and PhD in chemical engineering.[3]
Career
[edit]In 1985 Dekkers worked for General Electric (GE) in different research departments located in the US and the Netherlands. In 1988, he became Research Director of the GE range of polymers and subsequently held management positions in various other polymer units.
In 1995, Dekkers joined Allied Signal (later named Honeywell International Inc.)